The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).
The global Colorectal Cancer market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Colorectal Cancer in various end use industries.
The expanding demands from the Early Colorectal Cancer, Midterm Colorectal Cancer and Late Colorectal Cancer,, are propelling Colorectal Cancer market. Chemotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Targeted therapy segment is estimated at % CAGR for the next seven-year period.
The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Colorectal Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Colorectal Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Colorectal Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Colorectal Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Colorectal Cancer covered in this report include Roche, Debiopharm, Merck Kgaa, Vaccinogen, Aeterna Zentaris, Keryx, Spectrum Pharmaceuticals, Mologen and Amgen, etc.
The global Colorectal Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Roche
- Debiopharm
- Merck Kgaa
- Vaccinogen
- Aeterna Zentaris
- Keryx
- Spectrum Pharmaceuticals
- Mologen
- Amgen
- Bayer Healthcare
Global Colorectal Cancer market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Colorectal Cancer market, Segment by Type:
- Chemotherapy
- Targeted therapy
- Immunotherapy
Global Colorectal Cancer market, by Application
- Early Colorectal Cancer
- Midterm Colorectal Cancer
- Late Colorectal Cancer
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Colorectal Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Colorectal Cancer
1.1 Colorectal Cancer Market Overview
1.1.1 Colorectal Cancer Product Scope
1.1.2 Colorectal Cancer Market Status and Outlook
1.2 Global Colorectal Cancer Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Colorectal Cancer Market Size by Region (2018-2029)
1.4 Global Colorectal Cancer Historic Market Size by Region (2018-2023)
1.5 Global Colorectal Cancer Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Colorectal Cancer Market Size (2018-2029)
1.6.1 North America Colorectal Cancer Market Size (2018-2029)
1.6.2 Europe Colorectal Cancer Market Size (2018-2029)
1.6.3 Asia-Pacific Colorectal Cancer Market Size (2018-2029)
1.6.4 Latin America Colorectal Cancer Market Size (2018-2029)
1.6.5 Middle East & Africa Colorectal Cancer Market Size (2018-2029)
2 Colorectal Cancer Market by Type
2.1 Introduction
2.1.1 Chemotherapy
2.1.2 Targeted therapy
2.1.3 Immunotherapy
2.2 Global Colorectal Cancer Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Colorectal Cancer Historic Market Size by Type (2018-2023)
2.2.2 Global Colorectal Cancer Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Colorectal Cancer Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Colorectal Cancer Revenue Breakdown by Type (2018-2029)
3 Colorectal Cancer Market Overview by Application
3.1 Introduction
3.1.1 Early Colorectal Cancer
3.1.2 Midterm Colorectal Cancer
3.1.3 Late Colorectal Cancer
3.2 Global Colorectal Cancer Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Colorectal Cancer Historic Market Size by Application (2018-2023)
3.2.2 Global Colorectal Cancer Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Colorectal Cancer Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Colorectal Cancer Revenue Breakdown by Application (2018-2029)
4 Colorectal Cancer Competition Analysis by Players
4.1 Global Colorectal Cancer Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer as of 2022)
4.3 Date of Key Players Enter into Colorectal Cancer Market
4.4 Global Top Players Colorectal Cancer Headquarters and Area Served
4.5 Key Players Colorectal Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 Colorectal Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Colorectal Cancer Products, Services and Solutions
5.1.4 Roche Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Debiopharm
5.2.1 Debiopharm Profile
5.2.2 Debiopharm Main Business
5.2.3 Debiopharm Colorectal Cancer Products, Services and Solutions
5.2.4 Debiopharm Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.2.5 Debiopharm Recent Developments
5.3 Merck Kgaa
5.3.1 Merck Kgaa Profile
5.3.2 Merck Kgaa Main Business
5.3.3 Merck Kgaa Colorectal Cancer Products, Services and Solutions
5.3.4 Merck Kgaa Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.3.5 Vaccinogen Recent Developments
5.4 Vaccinogen
5.4.1 Vaccinogen Profile
5.4.2 Vaccinogen Main Business
5.4.3 Vaccinogen Colorectal Cancer Products, Services and Solutions
5.4.4 Vaccinogen Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.4.5 Vaccinogen Recent Developments
5.5 Aeterna Zentaris
5.5.1 Aeterna Zentaris Profile
5.5.2 Aeterna Zentaris Main Business
5.5.3 Aeterna Zentaris Colorectal Cancer Products, Services and Solutions
5.5.4 Aeterna Zentaris Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.5.5 Aeterna Zentaris Recent Developments
5.6 Keryx
5.6.1 Keryx Profile
5.6.2 Keryx Main Business
5.6.3 Keryx Colorectal Cancer Products, Services and Solutions
5.6.4 Keryx Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.6.5 Keryx Recent Developments
5.7 Spectrum Pharmaceuticals
5.7.1 Spectrum Pharmaceuticals Profile
5.7.2 Spectrum Pharmaceuticals Main Business
5.7.3 Spectrum Pharmaceuticals Colorectal Cancer Products, Services and Solutions
5.7.4 Spectrum Pharmaceuticals Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.7.5 Spectrum Pharmaceuticals Recent Developments
5.8 Mologen
5.8.1 Mologen Profile
5.8.2 Mologen Main Business
5.8.3 Mologen Colorectal Cancer Products, Services and Solutions
5.8.4 Mologen Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.8.5 Mologen Recent Developments
5.9 Amgen
5.9.1 Amgen Profile
5.9.2 Amgen Main Business
5.9.3 Amgen Colorectal Cancer Products, Services and Solutions
5.9.4 Amgen Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.9.5 Amgen Recent Developments
5.10 Bayer Healthcare
5.10.1 Bayer Healthcare Profile
5.10.2 Bayer Healthcare Main Business
5.10.3 Bayer Healthcare Colorectal Cancer Products, Services and Solutions
5.10.4 Bayer Healthcare Colorectal Cancer Revenue (US$ Million) & (2018-2023)
5.10.5 Bayer Healthcare Recent Developments
6 North America
6.1 North America Colorectal Cancer Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Colorectal Cancer Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Colorectal Cancer Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Colorectal Cancer Market Dynamics
11.1 Colorectal Cancer Industry Trends
11.2 Colorectal Cancer Market Drivers
11.3 Colorectal Cancer Market Challenges
11.4 Colorectal Cancer Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
